LaMarca and co-workers have reported that pregnant rats infused with purified AT1-AA between gestational days 12–19 demonstrated high blood pressure and high serum AT1-AA levels as well as dysregulated angiogenic factor levels and increased tissue levels of prepro-endothelin-1 in comparison to normotensive pregnant control rats [50]. This evidence concerns the gene EDN1 and hypertensive disorder.